Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Venous Thrombosis

  Free Subscription


Articles published in Thromb Res

Retrieve available abstracts of 312 articles:
HTML format



Single Articles


    December 2023
  1. TRITSCHLER T, Sadeghipour P, Bikdeli B
    Subgroup analysis in randomized controlled trials: Useful or misleading?
    Thromb Res. 2023;232:160-162.
    PubMed    


    November 2023
  2. LIPPI G, Mattiuzzi C, Favaloro EJ
    Recent monthly mortality for pulmonary embolism in the US.
    Thromb Res. 2023;233:99-100.
    PubMed    


  3. INGEMANN-MOLDEN S, Caspersen CK, Rolving N, Hojen AA, et al
    Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review.
    Thromb Res. 2023;233:69-81.
    PubMed     Abstract available


  4. NAJARRO M, Briceno W, Rodriguez C, Muriel A, et al
    Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2023;233:18-24.
    PubMed     Abstract available


  5. APARICIO I, Iranzo P, Reyes R, Bote H, et al
    Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
    Thromb Res. 2023;232:133-137.
    PubMed     Abstract available


  6. CHEN AC, Rao AS, Oropallo A, Goldhaber SZ, et al
    Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
    Thromb Res. 2023;232:123-132.
    PubMed     Abstract available


  7. HEERINK JS, Oudega R, Gemen E, Hopstaken R, et al
    Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism.
    Thromb Res. 2023;232:113-122.
    PubMed     Abstract available


  8. ZABCZYK M, Kruk A, Natorska J, Undas A, et al
    Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype.
    Thromb Res. 2023;232:70-76.
    PubMed     Abstract available


  9. BIKDELI B, Piazza G
    The CORONA-VTE network registry: Revisiting the realities while encouraging enthusiasm.
    Thromb Res. 2023;231:7.
    PubMed    


    October 2023
  10. PAREDES D, Del Carmen Diaz-Pedroche M, Gomez-Cuervo C, Perez-Jacoiste A, et al
    Identifying patients with prostate cancer at increased risk for haematuria during anticoagulation for venous thromboembolism.
    Thromb Res. 2023;232:54-61.
    PubMed     Abstract available


  11. KAPTEIJN MY, Lanting VR, Kaptein FHJ, Guman NAM, et al
    RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.
    Thromb Res. 2023;232:27-34.
    PubMed     Abstract available


  12. TSUJISAKA Y, Yamashita Y, Morimoto T, Takase T, et al
    Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
    Thromb Res. 2023;232:35-42.
    PubMed     Abstract available


  13. ISHISAKA Y, Watanabe A, Takagi H, Steiger D, et al
    Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis.
    Thromb Res. 2023;231:91-98.
    PubMed     Abstract available


  14. YHIM HY, Lee J, Kim KH, Kim SA, et al
    Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximab-based combination chemotherapy: A population-based study in Korea.
    Thromb Res. 2023;231:50-57.
    PubMed     Abstract available


    September 2023
  15. MAVROMANOLI AC, Jimenez D, Sanchez O, Sobkowicz B, et al
    Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis.
    Thromb Res. 2023;231:29-31.
    PubMed    


  16. RAMBAUD G, Mai V, Motreff C, Sanchez O, et al
    Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
    Thromb Res. 2023;231:58-64.
    PubMed     Abstract available


  17. XU Y, Khan F, Kovacs MJ, Sabri E, et al
    Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
    Thromb Res. 2023;231:32-38.
    PubMed     Abstract available


  18. DRAGSBAEK SJ, Lyhne MD, Hansen JV, Pedersen CCE, et al
    A porcine model of human-like chronic thromboembolic pulmonary disease.
    Thromb Res. 2023;231:25-28.
    PubMed    


  19. STALS MAM, Beenen LFM, Coppens M, Faber LM, et al
    Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
    Thromb Res. 2023;231:65-75.
    PubMed     Abstract available


  20. AVERY J, Guffey D, Ma S, Basom R, et al
    Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Thromb Res. 2023;229:1-6.
    PubMed     Abstract available


    August 2023
  21. CHU G, Seelig J, Cannegieter SC, Gelderblom H, et al
    Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
    Thromb Res. 2023;230:98-104.
    PubMed     Abstract available


  22. SCOTT DM, Abud A, Amor M, Saemi A, et al
    Natural Language Processing tool accurately identifies acute venous thromboembolism.
    Thromb Res. 2023;229:252-254.
    PubMed    


  23. FELIX G, Ferreira E, Ribeiro A, Guerreiro I, et al
    Predictors of cancer in patients with acute pulmonary embolism.
    Thromb Res. 2023;230:11-17.
    PubMed     Abstract available


    July 2023
  24. MEYER HJ, Gottschling S, Bar C, Wienke A, et al
    CT coronary calcium score is a prognostic marker in acute pulmonary embolism.
    Thromb Res. 2023;229:255-257.
    PubMed    


  25. BENZIDIA I, Robitaille C, Abualsaud A, McDonald L, et al
    Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2023;229:139-145.
    PubMed     Abstract available


  26. ANIJS RJS, Chen Q, van der Hulle T, Versteeg HH, et al
    Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
    Thromb Res. 2023;229:90-98.
    PubMed     Abstract available


  27. ALMAJDI A, Almutairi S, Alharbi M
    Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis.
    Thromb Res. 2023;229:77-85.
    PubMed     Abstract available


  28. HYDER SN, Han HB, Ash S, Horne BD, et al
    Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers.
    Thromb Res. 2023;227:45-50.
    PubMed     Abstract available


    June 2023
  29. LOWE G, Wu O, van Hylckama Vlieg A, Folsom A, et al
    Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis.
    Thromb Res. 2023;229:31-39.
    PubMed     Abstract available


  30. FILIPPI L, Turcato G, Milan M, Barbar S, et al
    Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.
    Thromb Res. 2023;229:73-76.
    PubMed     Abstract available


  31. JERVAN O, Dhayyat A, Gleditsch J, Haukeland-Parker S, et al
    Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism.
    Thromb Res. 2023;229:7-14.
    PubMed     Abstract available


  32. MUNOZ AJ, Souto JC, Lecumberri R, Obispo B, et al
    Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.
    Thromb Res. 2023;228:181-188.
    PubMed     Abstract available


  33. JAOUEN S, Mingant F, Lippert E, Galinat H, et al
    Using an age and fibrinogen levels adjusted D-dimer cutoff significantly improves the specificity of two equivalent D-dimer assays for excluding pulmonary embolism.
    Thromb Res. 2023;228:191-199.
    PubMed     Abstract available


  34. ZUIN M, Bikdeli B, Davies J, Krishnathasan D, et al
    Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019.
    Thromb Res. 2023;228:72-80.
    PubMed     Abstract available


  35. BROWN C, Brandt W, Wang TF, Delluc A, et al
    Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis.
    Thromb Res. 2023;228:81-84.
    PubMed     Abstract available


    May 2023
  36. OTERO R, Lobo JL, Lopez R, Fernandez C, et al
    Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
    Thromb Res. 2023;228:1-9.
    PubMed     Abstract available


  37. ADDA-REZIG I, Cossu J, Falvo N, Ecarnot F, et al
    Home treatment versus early discharge for the outpatient management of acute pulmonary embolism: A non-interventional, post-hoc cohort analysis.
    Thromb Res. 2023;227:25-33.
    PubMed     Abstract available


  38. PALLARES ROBLES A, Ten Cate V, Lenz M, Schulz A, et al
    Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification.
    Thromb Res. 2023 May 8:S0049-3848(23)00124.
    PubMed     Abstract available


    April 2023
  39. LI HY, Wang J, Wang T, Wang HS, et al
    Management of venous thromboembolism in pediatric patients: Quality assessment of clinical practice guidelines and variations in recommendations.
    Thromb Res. 2023;226:107-116.
    PubMed     Abstract available


  40. CHIU J, Lazo-Langner A
    Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review.
    Thromb Res. 2023;226:141-149.
    PubMed     Abstract available


  41. DROPPA M, Zdanyte M, Henes JK, Gawaz M, et al
    Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis.
    Thromb Res. 2023;226:33-35.
    PubMed    


  42. KAPTEIN FHJ, Kroft LJM, van Dam LF, Stoger JL, et al
    Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes.
    Thromb Res. 2023;226:51-55.
    PubMed     Abstract available


  43. KELLER K, Kohring C, Farmakis IT, Valerio L, et al
    Impact of venous thromboembolism on incidence of arterial thromboembolism - An analysis of German outpatient claims data.
    Thromb Res. 2023;226:9-17.
    PubMed     Abstract available


  44. QIAO N, Zhang Q, Chen L, He W, et al
    Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
    Thromb Res. 2023;226:1-8.
    PubMed     Abstract available


  45. COHEN A, Noxon V, Dhamane A, Bruette R, et al
    Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer.
    Thromb Res. 2023;226:117-126.
    PubMed     Abstract available


    March 2023
  46. ZBINDEN S, Voci D, Grigorean A, Holy EW, et al
    Clinical outcomes of ultrasound-assisted coagulation monitoring-adjusted catheter-directed thrombolysis for acute pulmonary embolism.
    Thromb Res. 2023;225:73-78.
    PubMed     Abstract available


  47. MATUSOV Y, Yaqoob M, Karumanchi A, Lipshutz HG, et al
    Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli.
    Thromb Res. 2023;225:57-62.
    PubMed     Abstract available


  48. KRECAK I, Grohovac D, Vucenovic Basic N, Ceko M, et al
    Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
    Thromb Res. 2023 Mar 21:S0049-3848(23)00078.
    PubMed    


  49. ABDELHAY A, Mahmoud AA, Mostafa M, Al Ali O, et al
    Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
    Thromb Res. 2023;225:28-32.
    PubMed     Abstract available


    February 2023
  50. WIKLUND P, Medson K, Elf J
    Unreported incidental pulmonary embolism in patients with cancer: Radiologic natural history and risk of recurrent venous thromboembolism and death.
    Thromb Res. 2023;224:65-72.
    PubMed     Abstract available


  51. PRANDONI P, Bilora F, Mahe I, Varona JF, et al
    The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2023;224:17-20.
    PubMed    


  52. ROHATGI N, Dahlen A, Berube C, Weng Y, et al
    Characteristics associated with diagnostic yield of imaging for deep venous thrombosis and pulmonary embolism in the emergency department, hospital, and office settings: An Optum Clinformatics claims database study (2015-2019).
    Thromb Res. 2023;224:4-12.
    PubMed     Abstract available


  53. ZHANG C, Deng Z, Yang Z, Xie J, et al
    A nomogram model to predict the acute venous thromboembolism risk after surgery in patients with glioma.
    Thromb Res. 2023;224:21-31.
    PubMed     Abstract available


  54. VOSTATEK R, Hohensinner P, Nopp S, Haider P, et al
    Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolism.
    Thromb Res. 2023;223:168-173.
    PubMed     Abstract available


    January 2023
  55. MIRAMBEAUX R, Rodriguez C, Muriel A, Gonzalez S, et al
    Comparison of various prognostic scores for identification of patients with intermediate-high risk pulmonary embolism.
    Thromb Res. 2023;223:61-68.
    PubMed     Abstract available


  56. ANDO K, Natsumeda M, Kawamura M, Shirakawa K, et al
    Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.
    Thromb Res. 2023;223:36-43.
    PubMed     Abstract available


  57. CIRES-DROUET R, LaRocco A, Soldin D, John T, et al
    Left ventricular systolic dysfunction during acute pulmonary embolism.
    Thromb Res. 2023;223:1-6.
    PubMed     Abstract available


  58. OGUNSOLA AS, Farhadi K, Mercy UC, Elenwa F, et al
    Analysis of contemporary mortality trends in pulmonary embolism, United States, 1999-2020.
    Thromb Res. 2023;223:53-60.
    PubMed     Abstract available


  59. KONG J, Hardwick A, Jiang SF, Sun K, et al
    CTEPH: A Kaiser Permanente Northern California Experience.
    Thromb Res. 2023;221:130-136.
    PubMed     Abstract available


  60. ZHENG C, Ma J, Xu J, Wu L, et al
    The optimal regimen, efficacy and safety of tranexamic acid and aminocaproic acid to reduce bleeding for patients after total hip arthroplasty: A systematic review and Bayesian network meta-analysis.
    Thromb Res. 2023;221:120-129.
    PubMed     Abstract available


    December 2022
  61. CHOPARD R, Campia U, Jering KS, Almarzooq ZI, et al
    Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center.
    Thromb Res. 2022;222:113-116.
    PubMed    


  62. FISCHER S, Meisinger C, Linseisen J, Berghaus TM, et al
    Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors.
    Thromb Res. 2022;222:68-74.
    PubMed     Abstract available


  63. MAXIMILIANO CL, Jaime GC, Erika MH
    Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban.
    Thromb Res. 2022;222:43-48.
    PubMed     Abstract available


  64. YU JL, Lane M, Roach GD, Morrison SD, et al
    Perioperative venous thromboembolism risk considerations in the gender diverse patient - Should we consider more than just estrogen?
    Thromb Res. 2022;222:40-42.
    PubMed    


  65. PRANDONI P, Gabara C, Bilora F, Aibar J, et al
    Age over 75 does not increase the risk of recurrent venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;222:16-19.
    PubMed    


  66. HASSAN E, Motwani J
    Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism.
    Thromb Res. 2022;221:92-96.
    PubMed     Abstract available


    November 2022
  67. IDING AFJ, Kremers BMM, Nagy M, Robles AP, et al
    Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
    Thromb Res. 2022;221:58-64.
    PubMed    


  68. ARDESHIRROUHANIFARD S, Ellenbogen MI, Segal JB, Streiff MB, et al
    Healthcare utilization differences between an apixaban-based and warfarin-based strategy for acute venous thromboembolism in patients with end-stage kidney disease.
    Thromb Res. 2022;221:45-50.
    PubMed     Abstract available


  69. ARDESHNA NS, Song M, Hyder SN, Grace KA, et al
    Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experience.
    Thromb Res. 2022;221:73-78.
    PubMed     Abstract available


  70. TURPIE AGG, Farjat AE, Haas S, Ageno W, et al
    36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2022;222:31-39.
    PubMed     Abstract available


  71. KAPTEIN FHJ, Stals MAM, Evenhuis RE, Gelderblom H, et al
    Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
    Thromb Res. 2022;221:19-25.
    PubMed     Abstract available


  72. STEINER D, Nopp S, Weber B, Schlager O, et al
    The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study.
    Thromb Res. 2022;221:1-6.
    PubMed     Abstract available


  73. KAPTEIJN MY, Kaptein FHJ, Stals MAM, Klaase EE, et al
    Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
    Thromb Res. 2022;221:10-18.
    PubMed     Abstract available


  74. WYSOKINSKI WE, Houghton DE, Vlazny DT, Ashrani AA, et al
    Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
    Thromb Res. 2022;221:37-44.
    PubMed     Abstract available


  75. BJORNHART B, Kristiansen C, Asmussen J, Hansen KH, et al
    Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy.
    Thromb Res. 2022 Nov 5. pii: S0049-3848(22)00438.
    PubMed     Abstract available


    October 2022
  76. KNUEPPEL P, Bang SH, Troyer C, Barriga A, et al
    Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
    Thromb Res. 2022;220:91-96.
    PubMed     Abstract available


  77. SILVEY M, Nguyen ATH, Amankwah EK, McElwaine E, et al
    Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium.
    Thromb Res. 2022;220:116-120.
    PubMed     Abstract available


  78. WENGER N, Sebastian T, Beer JH, Mazzolai L, et al
    Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Res. 2022;220:65-71.
    PubMed     Abstract available


  79. BAIDILDINOVA G, Ten Cate V, Nagler M, Panova-Noeva M, et al
    Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism.
    Thromb Res. 2022;220:75-87.
    PubMed     Abstract available


  80. RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Abdel-Kader-Martin L, Otero-Candelera R, et al
    Subgroup analyses in venous thromboembolism trials reporting pharmacological interventions: A systematic review.
    Thromb Res. 2022 Oct 11. pii: S0049-3848(22)00405.
    PubMed     Abstract available


  81. MARTIN KA, Lyleroehr MJ, Cameron KA
    Barriers and facilitators to preventing venous thromboembolism in oncology practice.
    Thromb Res. 2022;220:21-23.
    PubMed    


    September 2022
  82. GRIS JC, Bourguignon C, Bouvier S, Nouvellon E, et al
    Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholipid syndrome: International retrospective study of outcomes.
    Thromb Res. 2022;219:102-108.
    PubMed     Abstract available


  83. ALBLAS H, van Kan C, van Het Westeinde SC, Emmering J, et al
    Persistent dyspnea after acute pulmonary embolism is related to perfusion defects and lower long-term quality of life.
    Thromb Res. 2022;219:89-94.
    PubMed    


  84. SPEKSNIJDER EM, Hessels LM, Muusses L, Buller HR, et al
    Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients.
    Thromb Res. 2022;219:109-111.
    PubMed    


  85. KELLER K, Sivanathan V, Schmitt VH, Ostad MA, et al
    Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease.
    Thromb Res. 2022;219:77-85.
    PubMed     Abstract available


  86. LUI B, Wee B, Lai J, Khattak Z, et al
    A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant - Has venous thromboembolism treatment become safer?
    Thromb Res. 2022;219:112-120.
    PubMed     Abstract available


  87. YAMASHITA Y, Morimoto T, Kadota K, Takase T, et al
    Causes of long-term mortality in patients with venous thromboembolism in the real world: From the COMMAND VTE registry.
    Thromb Res. 2022;219:30-39.
    PubMed     Abstract available


  88. SONNE-HOLM E, Kjaergaard J, Bang LE, Kober L, et al
    Educational differences in mortality but not in risk of recurrence following first-time pulmonary embolism: A Danish nationwide register-based study.
    Thromb Res. 2022;219:22-29.
    PubMed    


  89. LOW SK, Anjum Z, Mahmoud A, Joshi U, et al
    Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.
    Thromb Res. 2022;219:14-21.
    PubMed     Abstract available


  90. BORST JM, Modi RN, Kirchberg TN, Box K, et al
    You're never too old for optimal venous thromboembolism prophylaxis: Re-thinking current trauma guidelines.
    Thromb Res. 2022;218:186-188.
    PubMed    


    August 2022
  91. VOIGTLAENDER M, Edler C, Gerling M, Schadler J, et al
    Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors.
    Thromb Res. 2022;218:171-176.
    PubMed     Abstract available


  92. PRANDONI P, Bilora F, Pesavento R, Sancho T, et al
    The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry.
    Thromb Res. 2022;218:44-47.
    PubMed    


  93. GORAN K
    Search for obtaining the highest net clinical benefit in pulmonary embolism patients: A new improvement considering the safety of thrombolysis.
    Thromb Res. 2022;218:5-7.
    PubMed    


  94. MESSI M, Beneyto Afonso C, Stalder O, Mean M, et al
    Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment.
    Thromb Res. 2022;218:64-71.
    PubMed     Abstract available


  95. WANG WD, Wei JP, Gao RQ, Yang QC, et al
    A retrospective study of the role of preoperative ultrasonography in the detection of deep vein thrombosis in 1750 patients with gastric and colorectal cancers.
    Thromb Res. 2022;216:52-58.
    PubMed     Abstract available


  96. WIEGERS HMG, Scheres LJJ, Tahir L, Hutten BA, et al
    Risk of venous thromboembolism in women with endometriosis.
    Thromb Res. 2022;217:104-106.
    PubMed    


    July 2022
  97. ATA F, Ibrahim WH, Choudry H, Shams A, et al
    Optimal management, prevalence, and clinical behavior of saddle pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2022;217:86-95.
    PubMed     Abstract available


  98. CHOI SH, Nguyen H, Kanjwal S, Ibrahim I, et al
    COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data.
    Thromb Res. 2022;217:60-63.
    PubMed    


  99. MAHARAJ S, Chang S, Kloecker G, Chesney J, et al
    Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy.
    Thromb Res. 2022;217:48-51.
    PubMed    


  100. ZUIN M, Rigatelli G, Bilato C, Bongarzoni A, et al
    Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry.
    Thromb Res. 2022;217:15-21.
    PubMed    


  101. PANCANI R, Villari L, Aquilini F, Palla A, et al
    Prognostic role of respiratory failure in acute pulmonary embolism: a prospective multicenter study.
    Thromb Res. 2022;217:33-35.
    PubMed    


  102. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    PubMed     Abstract available


    June 2022
  103. FANG MC, Go AS, Prasad PA, Zhou HX, et al
    Health-related quali ty of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Thromb Res. 2022;216:97-102.
    PubMed     Abstract available


  104. SHIBAHASHI E, Jujo K, Kuroda S, Matsumoto S, et al
    Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
    Thromb Res. 2022;216:90-96.
    PubMed     Abstract available


  105. VEETTIL SK, Harris J, Syeed MS, Thakkinstian A, et al
    Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis.
    Thromb Res. 2022;216:74-83.
    PubMed     Abstract available


  106. SHEN J, Casie Chetty S, Shokouhi S, Maharjan J, et al
    Massive external validation of a machine learning algorithm to predict pulmonary embolism in hospitalized patients.
    Thromb Res. 2022;216:14-21.
    PubMed     Abstract available


  107. GUMAN NAM, van Haaps TF, van Es N, Leeflang MMG, et al
    Interrater agreement of two scales on the severity of anticoagulant-related major bleeding in patients with venous thromboembolism.
    Thromb Res. 2022;216:11-13.
    PubMed    


    May 2022
  108. BRANDT W, Brown C, Wang TF, Tagalakis V, et al
    Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial.
    Thromb Res. 2022;216:8-10.
    PubMed     Abstract available


  109. SUBHANI M, Sheth A, Ahmed J, Wijayasiri P, et al
    Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
    Thromb Res. 2022;215:19-29.
    PubMed     Abstract available


  110. OBRADOVIC S, Subotic B, Dzudovic B, Matijasevic J, et al
    Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.
    Thromb Res. 2022;214:138-143.
    PubMed     Abstract available


  111. BIKDELI B, Piazza G, Jimenez D, Muriel A, et al
    Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
    Thromb Res. 2022;214:122-131.
    PubMed     Abstract available


  112. ROSA V, Chaar CIO, Espitia O, Otalora S, et al
    A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome.
    Thromb Res. 2022;213:65-70.
    PubMed     Abstract available


  113. BARBERO E, Manas E, Bikdeli B, Garcia-Ortega A, et al
    Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism.
    Thromb Res. 2022;214:87-92.
    PubMed     Abstract available


  114. MONREAL M, Bertoletti L, Lopez-Nunez JJ, Tiberio G, et al
    TEMPORARY REMOVAL: OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study.
    Thromb Res. 2022;213 Suppl 2:S8-S9.
    PubMed     Abstract available


  115. BOSCH FTM, Campello E, Henderson MW, Mulder FI, et al
    TEMPORARY REMOVAL: OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study.
    Thromb Res. 2022;213 Suppl 2:S4.
    PubMed     Abstract available


  116. OVERVAD TF, Ording AG, Nielsen PB, Piazza G, et al
    TEMPORARY REMOVAL: OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors.
    Thromb Res. 2022;213 Suppl 2:S4-S5.
    PubMed     Abstract available


  117. ANTONUCCI E, Barcella L, Russo L, Chistolini A, et al
    TEMPORARY REMOVAL: PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry.
    Thromb Res. 2022;213 Suppl 2:S39.
    PubMed     Abstract available


  118. MARTIN AM, Lecumberri R, Souto JC, Aparicio J, et al
    TEMPORARY REMOVAL: PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients.
    Thromb Res. 2022;213 Suppl 2:S38-S39.
    PubMed     Abstract available


  119. LOPEZ-NUNEZ JJ, Trujillo-Santos J, Bertoletti L, Lobo JL, et al
    TEMPORARY REMOVAL: PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study.
    Thromb Res. 2022;213 Suppl 2:S37-S38.
    PubMed     Abstract available


  120. SALGADO M, Molina R, Vazquez EB, Martinez E, et al
    TEMPORARY REMOVAL: PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study.
    Thromb Res. 2022;213 Suppl 2:S36-S37.
    PubMed     Abstract available


  121. DONADINI MP, Squizzato A, Ferrazzi P, Maggioni S, et al
    TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study.
    Thromb Res. 2022;213 Suppl 2:S30-S31.
    PubMed     Abstract available


  122. ANIJS RJS, Chen Q, Lijfering WM, Cannegieter SC, et al
    TEMPORARY REMOVAL: OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis.
    Thromb Res. 2022;213 Suppl 2:S3.
    PubMed     Abstract available


  123. HAQUE F, Jawad N, Brzuszek A, Birk R, et al
    TEMPORARY REMOVAL: PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients.
    Thromb Res. 2022;213 Suppl 2:S28.
    PubMed     Abstract available


  124. FORESTA A, Colacioppo P, Baviera M, Ojeda-Fernandez L, et al
    TEMPORARY REMOVAL: PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer.
    Thromb Res. 2022;213 Suppl 2:S27-S28.
    PubMed     Abstract available


  125. DAGUENET E, Maison M, Tinquaut F, Giroux EA, et al
    TEMPORARY REMOVAL: PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study.
    Thromb Res. 2022;213 Suppl 2:S21.
    PubMed     Abstract available


  126. ALBERTSEN IE, Lyhne NM, Larsen TB, Nielsen PB, et al
    TEMPORARY REMOVAL: PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study.
    Thromb Res. 2022;213 Suppl 2:S21-S22.
    PubMed     Abstract available


  127. MORAN LO, Pesantez D, Vazquez EB, Garay DF, et al
    TEMPORARY REMOVAL: PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer.
    Thromb Res. 2022;213 Suppl 2:S20.
    PubMed     Abstract available


  128. GERVASO L, Laffi A, Meneses-Medina MI, Cella CA, et al
    TEMPORARY REMOVAL: PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms.
    Thromb Res. 2022;213 Suppl 2:S19-S20.
    PubMed     Abstract available


  129. JORGENSEN H, Horvath-Puho E, Laugesen K, Braekkan S, et al
    TEMPORARY REMOVAL: PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism.
    Thromb Res. 2022;213 Suppl 2:S18-S19.
    PubMed     Abstract available


  130. SILVA-CARDENAS DC, Pikabea-Diaz F, Zumarraga-Cuesta A, Lopez-Santillan M, et al
    TEMPORARY REMOVAL: PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients.
    Thromb Res. 2022;213 Suppl 2:S17.
    PubMed     Abstract available


  131. CHARLES S, Chaudier A, Fatrara T, Daguenet E, et al
    TEMPORARY REMOVAL: PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma.
    Thromb Res. 2022;213 Suppl 2:S13.
    PubMed     Abstract available


  132. TROELSEN FS, Vago EK, Horvath-Puho E, van Es N, et al
    TEMPORARY REMOVAL: PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study.
    Thromb Res. 2022;213 Suppl 2:S11.
    PubMed     Abstract available


  133. JAKOBSEN SS, Frokjaer JB, Fisker RV, Kristensen SR, et al
    TEMPORARY REMOVAL: PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients.
    Thromb Res. 2022;213 Suppl 2:S11-S12.
    PubMed     Abstract available


  134. RUIZ M, Martin AM, Font C, Castellon V, et al
    TEMPORARY REMOVAL: OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study.
    Thromb Res. 2022;213 Suppl 2:S1.
    PubMed     Abstract available


  135. MCCRAE KR, Swaidani S, Diaz-Montero CM, Khorana AA, et al
    Old is new again: emergence of thromboembolic complications in cancer patients on immunotherapy.
    Thromb Res. 2022;213.
    PubMed     Abstract available


  136. MOIK F, Ay C
    Venous and arterial thromboembolism in patients with cancer treated with targeted anti-cancer therapies.
    Thromb Res. 2022;213 Suppl 1:S58-S65.
    PubMed     Abstract available


  137. DELLUC A, Robin P
    (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?
    Thromb Res. 2022;213 Suppl 1:S42-S45.
    PubMed     Abstract available


  138. MANTHA S, Rak J
    Cancer genetic alterations and risk of venous thromboembolism.
    Thromb Res. 2022;213 Suppl 1:S29-S34.
    PubMed     Abstract available


  139. SANFILIPPO KM
    Venous thromboembolism and risk stratification in hematological malignancies.
    Thromb Res. 2022;213 Suppl 1:S16-S21.
    PubMed     Abstract available


    April 2022
  140. NOUMEGNI SR, Didier R, Mansourati V, Tromeur C, et al
    Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Thromb Res. 2022;214:93-105.
    PubMed     Abstract available


  141. LIND MM, Johansson M, Sjalander A, Johansson L, et al
    Incidence and risk factors of venous thromboembolism in men and women.
    Thromb Res. 2022;214:82-86.
    PubMed     Abstract available


  142. PORFIDIA A, Esposto G, Manzo C, Santini P, et al
    No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19.
    Thromb Res. 2022;214:44-46.
    PubMed    


  143. RUSSO F, Cianfanelli L, Chieffo A, Galli M, et al
    Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience.
    Thromb Res. 2022;214:40-43.
    PubMed    


  144. CATELLA J, Bertoletti L, Moustafa F, Nieto JA, et al
    Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
    Thromb Res. 2022;214:29-36.
    PubMed     Abstract available


    March 2022
  145. ROBERTS LN, Navaratnam AV, Arya R, Briggs TWR, et al
    Venous thromboembolism in patients hospitalised with COVID-19 in England.
    Thromb Res. 2022;213:138-144.
    PubMed     Abstract available


  146. VAN DER VLEUTEN CJM, Zwerink LGJM, Klappe EM, de Jong EMGJ, et al
    Is there a place for prophylaxis with DOACs in Klippel-Trenaunay syndrome and other low-flow vascular malformations with intravascular coagulopathy and thromboembolic events?
    Thromb Res. 2022;213:30-33.
    PubMed    


  147. BOVA C, Vigna E, Gentile M, Pignataro FS, et al
    Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis.
    Thromb Res. 2022;213:43-46.
    PubMed    


  148. ABUFARHANEH M, Pandya RK, Alkhaja A, Iansavichene A, et al
    Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
    Thromb Res. 2022;213:47-56.
    PubMed     Abstract available


  149. PALARETI G, Bignamini AA, Urbanek T, Cini M, et al
    Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study.
    Thromb Res. 2022;211:140-146.
    PubMed     Abstract available


    February 2022
  150. ABRUZZO A, Gorantla V, Thomas SE
    Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review.
    Thromb Res. 2022;212:58-71.
    PubMed     Abstract available


  151. CATELLA J, Joly M, Pernod G
    Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?
    Thromb Res. 2022;213:8.
    PubMed    


  152. VOCI D, Fedeli U, Farmakis IT, Hobohm L, et al
    Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area.
    Thromb Res. 2022;212:44-50.
    PubMed     Abstract available


  153. DANIELSBACKA JS, Mannerkorpi K, Olsen MF
    Health care professionals' conceptions of respiratory symptoms and physical activity in patients with acute pulmonary embolism. A phenomenographic interview study.
    Thromb Res. 2022;212:22-29.
    PubMed     Abstract available


  154. BONNESEN K, Heide-Jorgensen U, Albertsen LW, Schmidt SAJ, et al
    Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism.
    Thromb Res. 2022;212:9-18.
    PubMed     Abstract available


  155. TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
    Advances in treatment of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2022;212:30-37.
    PubMed     Abstract available


  156. BEAUDOIN E, Kaka S, Gagnon E, Durivage A, et al
    Use of D-dimer for the exclusion of new pulmonary embolism in anticoagulated patients: A multicenter retrospective study.
    Thromb Res. 2022;212:19-21.
    PubMed    


  157. BETENSKY M, Kumar R, Hankins JS, Goldenberg NA, et al
    Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
    Thromb Res. 2022;211:133-139.
    PubMed     Abstract available


  158. KALAITZOPOULOS DR, Panagopoulos A, Samant S, Ghalib N, et al
    Management of venous thromboembolism in pregnancy.
    Thromb Res. 2022;211:106-113.
    PubMed     Abstract available


    January 2022
  159. KALAYCI A, Gibson CM, Hernandez AF, Hull RD, et al
    Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
    Thromb Res. 2022;211:63-69.
    PubMed     Abstract available


  160. SHEN Y, Zhang Y, Xiong Y, Zhang Z, et al
    Whole exome sequencing identifies genetic variants in Chinese Han pregnant women with venous thromboembolism.
    Thromb Res. 2022;211:49-55.
    PubMed     Abstract available


  161. POHL KR, Hobohm L, Krieg VJ, Sentler C, et al
    Impact of thyroid dysfunction on short-term outcomes and long-term mortality in patients with pulmonary embolism.
    Thromb Res. 2022;211:70-78.
    PubMed     Abstract available


  162. CABALLERO-ERASO C, Lopez-Ramirez C, Marin-Romero S, Carrera-Cueva C, et al
    Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study.
    Thromb Res. 2022;211:81-84.
    PubMed    


  163. BIKDELI B, Moustafa F, Nieto JA, Lee AI, et al
    Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism.
    Thromb Res. 2022;211:10-18.
    PubMed     Abstract available


    December 2021
  164. PETRELLI F, Cabiddu M, Borgonovo K, Parati MC, et al
    Osimertinib-related venous thromboembolism in non small lung cancer.
    Thromb Res. 2021;210:63-66.
    PubMed    


  165. SIMARD C, Malhame I, Skeith L, Carson MP, et al
    Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.
    Thromb Res. 2021;210:20-25.
    PubMed     Abstract available


  166. WANG L, Wei S, Zhou B, Wu S, et al
    Corrigendum to "A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors" [Thromb. Res. 202, June 2021, 52-58].
    Thromb Res. 2021;210:4-5.
    PubMed    


  167. SONNE-HOLM E, Kjaergaard J, Bang LE, Fosbol E, et al
    Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999-2018.
    Thromb Res. 2021;210:12-19.
    PubMed     Abstract available


  168. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
    Thromb Res. 2021;209:105.
    PubMed    


  169. ZUIN M, Engelen MM, Barco S, Spyropoulos AC, et al
    Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.
    Thromb Res. 2021;209:94-98.
    PubMed    


  170. DE WINTER MA, Timmers T, Hovens MMC, Iglesias Del Sol A, et al
    Effect of an interactive, educational app about venous thromboembolism and anticoagulation on patient satisfaction: A randomized controlled trial.
    Thromb Res. 2021;209:86-93.
    PubMed     Abstract available


  171. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
    Thromb Res. 2021 Dec 1. pii: S0049-3848(21)00545.
    PubMed    


    November 2021
  172. VERMA AA, Masoom H, Pou-Prom C, Shin S, et al
    Developing and validating natural language processing algorithms for radiology reports compared to ICD-10 codes for identifying venous thromboembolism in hospitalized medical patients.
    Thromb Res. 2021;209:51-58.
    PubMed     Abstract available


  173. BOLZACCHINI E, Pomero F, Fazio M, Civitelli C, et al
    Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.
    Thromb Res. 2021;208:190-197.
    PubMed     Abstract available


  174. ZUIN M, Cervellati C, Rigatelli G, Zuliani G, et al
    Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
    Thromb Res. 2021;208:170-172.
    PubMed    


  175. GIRAUD M, Catella J, Cognet L, Helfer H, et al
    Management of acute venous thromboembolism in patients taking antiplatelet therapy.
    Thromb Res. 2021;208:156-161.
    PubMed     Abstract available


  176. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
    Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
    Thromb Res. 2021;208:106-111.
    PubMed     Abstract available


  177. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.
    PubMed    


    October 2021
  178. LEE A, Oley F Jr, Lo M, Fong R, et al
    Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
    Thromb Res. 2021;208:148-155.
    PubMed     Abstract available


  179. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
    Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
    Thromb Res. 2021;208:79-82.
    PubMed     Abstract available


  180. HILL H, Robinson M, Lu L, Slaughter D, et al
    Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Thromb Res. 2021;208:71-78.
    PubMed     Abstract available


  181. HANSEN ES, Rinde FB, Edvardsen MS, Hindberg K, et al
    Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Thromb Res. 2021;208:121-126.
    PubMed     Abstract available


  182. LI A, Brandt W, Brown C, Wang TF, et al
    Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
    Thromb Res. 2021;208:58-65.
    PubMed     Abstract available


  183. HAZELTINE MD, Guber RD, Buettner H, Dorfman JD, et al
    Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.
    Thromb Res. 2021;208:52-57.
    PubMed     Abstract available


  184. LI J, Yi J, Hua L, Su Y, et al
    Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer.
    Thromb Res. 2021;208:45-51.
    PubMed     Abstract available


  185. BALLERIE A, Nguyen Van R, Lacut K, Galinat H, et al
    Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes.
    Thromb Res. 2021;208:39-44.
    PubMed     Abstract available


  186. DOUILLET D, Riou J, Penaloza A, Moumneh T, et al
    Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts.
    Thromb Res. 2021;208:4-10.
    PubMed     Abstract available


  187. PASHA AK, McBane RD, Chaudhary R, Padrnos LJ, et al
    Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19.
    Thromb Res. 2021;207:150-157.
    PubMed     Abstract available


  188. BOON GJAM, Janssen SMJ, Barco S, Bogaard HJ, et al
    Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome.
    Thromb Res. 2021;206:66-75.
    PubMed     Abstract available


    September 2021
  189. TCHAIKOVSKI SN, Thomassen MCLGD, Stickeler E, Bremme K, et al
    Resistance to activated protein C and impaired TFPI activity in women with previous hormone-induced venous thromboembolism.
    Thromb Res. 2021;207:143-149.
    PubMed     Abstract available


  190. LUU IHY, Kroon FPB, Buijs J, Krdzalic J, et al
    Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department.
    Thromb Res. 2021;207:113-115.
    PubMed    


  191. MARTIN AM, Polistena P, Mahmud A, Bettridge B, et al
    Optimal enoxaparin dosing strategies for venous thromboembolism prophylaxis and treatment of high body weight patients.
    Thromb Res. 2021;207:116-122.
    PubMed     Abstract available


  192. GABET A, Grave C, Tuppin P, Emmerich J, et al
    Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic.
    Thromb Res. 2021;207:67-74.
    PubMed     Abstract available


  193. OHASHI Y, Ikeda M, Kunitoh H, Sasako M, et al
    One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Thromb Res. 2021 Sep 21. pii: S0049-3848(21)00464.
    PubMed     Abstract available


  194. OAKES M, Arastu A, Kato C, Somers J, et al
    Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone.
    Thromb Res. 2021;207:96-98.
    PubMed     Abstract available


    August 2021
  195. STESSEL B, Peeters J, Bruckers L, Nulens M, et al
    Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
    Thromb Res. 2021;206:139-141.
    PubMed    


  196. HAKSTEEN WE, Hilderink BN, Dujardin RWG, Jansen RR, et al
    Venous thromboembolism is not a risk factor for the development of bloodstream infections in critically ill COVID-19 patients.
    Thromb Res. 2021;206:128-130.
    PubMed    


  197. YAMAURA G, Ito T, Miyaji Y, Ueda N, et al
    Therapeutic efficacy of heparin and direct factor Xa inhibitors in cancer-associated cryptogenic ischemic stroke with venous thromboembolism.
    Thromb Res. 2021;206:99-103.
    PubMed     Abstract available


  198. WENGER N, Sebastian T, Engelberger RP, Kucher N, et al
    Pulmonary embolism and deep vein thrombosis: Similar but different.
    Thromb Res. 2021;206:88-98.
    PubMed     Abstract available


  199. JOHNSON SA, Jones AE, Young E, Jennings C, et al
    A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
    Thromb Res. 2021;206:120-127.
    PubMed     Abstract available


  200. FERNANDO SM, Mathew R, Munshi L, Siegal DM, et al
    Media portrayals of pulmonary embolism.
    Thromb Res. 2021;206:52-54.
    PubMed    


  201. FILIPPI L, Sartori M, Facci M, Trentin M, et al
    Pulmonary embolism in patients with COVID-19 pneumonia: When we have to search for it?
    Thromb Res. 2021;206:29-32.
    PubMed     Abstract available


  202. HANNA-SAWIRES RG, Groen JV, Hamming A, Tollenaar RAEM, et al
    Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer.
    Thromb Res. 2021;207:134-139.
    PubMed     Abstract available


  203. KNOLL W, Fergusson N, Ivankovic V, Wang TF, et al
    Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature.
    Thromb Res. 2021;204:114-122.
    PubMed     Abstract available


    July 2021
  204. HOLSTEEN P, Meier M, Brennan L, VanHorn T, et al
    Safety and effectiveness of a risk-stratified venous thromboembolism prophylaxis algorithm in young people with cystic fibrosis.
    Thromb Res. 2021;206:36-41.
    PubMed     Abstract available


  205. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    PubMed     Abstract available


  206. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    PubMed     Abstract available


  207. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    PubMed    


  208. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    PubMed     Abstract available


  209. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    PubMed     Abstract available


  210. COHEN AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, et al
    Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study.
    Thromb Res. 2021;206:1-4.
    PubMed    


  211. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    PubMed    


  212. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    PubMed     Abstract available


    June 2021
  213. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    PubMed     Abstract available


  214. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    PubMed     Abstract available


  215. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    PubMed     Abstract available


  216. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    PubMed     Abstract available


  217. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    PubMed    


  218. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    PubMed     Abstract available


  219. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    PubMed     Abstract available


  220. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    PubMed    


  221. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    PubMed    


    May 2021
  222. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    PubMed     Abstract available


  223. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    PubMed    


  224. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    PubMed     Abstract available


  225. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    PubMed     Abstract available


  226. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    PubMed     Abstract available


  227. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    PubMed     Abstract available


  228. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    PubMed     Abstract available


  229. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    PubMed     Abstract available


  230. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    PubMed    


  231. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    PubMed     Abstract available


  232. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    PubMed     Abstract available


    April 2021
  233. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    PubMed     Abstract available


  234. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    PubMed     Abstract available


  235. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    PubMed    


    March 2021
  236. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    PubMed     Abstract available


  237. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    PubMed     Abstract available


  238. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    PubMed    


  239. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    PubMed     Abstract available


  240. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    PubMed     Abstract available


  241. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    PubMed    


  242. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    PubMed    


  243. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    PubMed     Abstract available


  244. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    PubMed     Abstract available


  245. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    PubMed     Abstract available


  246. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    PubMed    


  247. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    PubMed     Abstract available


  248. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    PubMed     Abstract available


  249. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    PubMed     Abstract available


    February 2021
  250. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    PubMed    


  251. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    PubMed     Abstract available


  252. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    PubMed     Abstract available


  253. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    PubMed     Abstract available


  254. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    PubMed     Abstract available


  255. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    PubMed    



  256. Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    PubMed    


    January 2021
  257. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    PubMed    


  258. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    PubMed     Abstract available


  259. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    PubMed    


  260. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    PubMed     Abstract available


  261. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    PubMed    


  262. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    PubMed     Abstract available


  263. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    PubMed     Abstract available


  264. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    PubMed    


  265. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    PubMed    


  266. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    PubMed     Abstract available


  267. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    PubMed     Abstract available


  268. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    PubMed    


  269. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    PubMed     Abstract available


    December 2020
  270. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    PubMed     Abstract available


  271. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    PubMed     Abstract available


  272. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    PubMed    


  273. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
    Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
    Thromb Res. 2020;199:32-34.
    PubMed    


  274. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
    Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Thromb Res. 2020;198:135-138.
    PubMed     Abstract available


  275. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
    Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
    Thromb Res. 2020;198:163-170.
    PubMed     Abstract available


  276. DE WIT K, Linkins LA
    A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
    Thromb Res. 2020;198:83-85.
    PubMed     Abstract available


  277. MIAO R, Dong X, Gong J, Wang Y, et al
    Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2020;198:122-131.
    PubMed     Abstract available


  278. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
    Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;198:103-114.
    PubMed     Abstract available


  279. WANG L, Chen F, Bai L, Yi Q, et al
    In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
    Thromb Res. 2020;196:541-542.
    PubMed    


  280. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
    COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Thromb Res. 2020;196:355-358.
    PubMed     Abstract available


    November 2020
  281. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
    Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Thromb Res. 2020;198:26-33.
    PubMed     Abstract available


  282. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
    Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
    Thromb Res. 2020;198:1-6.
    PubMed     Abstract available


  283. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
    Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
    Thromb Res. 2020;198:52-54.
    PubMed    


  284. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    PubMed     Abstract available


  285. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
    D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Thromb Res. 2020;197:160-164.
    PubMed     Abstract available


  286. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
    Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Thromb Res. 2020;197:144-152.
    PubMed     Abstract available


  287. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
    Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
    Thromb Res. 2020;197:94-99.
    PubMed     Abstract available


  288. ROBERGE G, Delluc A
    Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
    Thromb Res. 2020;197:77-83.
    PubMed     Abstract available


  289. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
    Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
    Thromb Res. 2020;197:48-55.
    PubMed     Abstract available


  290. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
    Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
    Thromb Res. 2020;197:8-12.
    PubMed     Abstract available


  291. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
    The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
    Thromb Res. 2020;195:228-230.
    PubMed    


  292. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
    Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
    Thromb Res. 2020;198:40-48.
    PubMed     Abstract available


    October 2020
  293. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
    Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
    Thromb Res. 2020;196:539-540.
    PubMed    


  294. SPEED V, Patel JP, Roberts LN, Patel RK, et al
    UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Thromb Res. 2020;197:16-19.
    PubMed    


  295. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
    The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
    Thromb Res. 2020;196:486-490.
    PubMed     Abstract available


  296. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
    PubMed    


  297. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
    Thromb Res. 2020;196:435-436.
    PubMed    


  298. HAN X, Li C, Zhang S, Hou X, et al
    Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
    Thromb Res. 2020;196:500-509.
    PubMed     Abstract available


  299. VALERIO L, Corsi G, Sebastian T, Barco S, et al
    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
    Thromb Res. 2020;196:494-499.
    PubMed     Abstract available


  300. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
    Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
    Thromb Res. 2020;196:476-482.
    PubMed     Abstract available


  301. GERSTEIN L, Koolian M, Schwartz BC
    Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
    Thromb Res. 2020;196:463-465.
    PubMed    


  302. DOYLE AJ, Thomas W, Retter A, Besser M, et al
    Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
    Thromb Res. 2020;196:454-456.
    PubMed    


  303. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
    Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
    Thromb Res. 2020;196:444-453.
    PubMed     Abstract available


  304. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
    Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
    Thromb Res. 2020;194:220-221.
    PubMed    


    September 2020
  305. YANG M, Qi J, Tang Y, Wu D, et al
    Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;196:410-413.
    PubMed    


  306. MA SG, Hu J, Huang Y
    The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Thromb Res. 2020;196:325-334.
    PubMed     Abstract available


  307. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
    D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Thromb Res. 2020;196:318-321.
    PubMed    


  308. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
    High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Thromb Res. 2020;196:349-354.
    PubMed     Abstract available


  309. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
    Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Thromb Res. 2020;196:308-312.
    PubMed     Abstract available


  310. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
    Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Thromb Res. 2020;196:313-317.
    PubMed     Abstract available


  311. DELATE T, Charlu M, Zhu S, Pai A, et al
    Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
    Thromb Res. 2020;196:367-370.
    PubMed     Abstract available


  312. MIRO O, Llorens P, Aguirre A, Lozano L, et al
    Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
    Thromb Res. 2020;196:322-324.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.